Thiazolidinediones and Macular Edema Comment on “Association Between...
The thiazolidinediones, rosiglitazone and pioglitazone, are peroxisome proliferator–activated receptor γ (PPAR-γ) agonists. They effectively reduce glycated hemoglobin among patients with type 2...
View ArticleAssociation Between Thiazolidinedione Treatment and Risk of Macular Edema...
BackgroundFindings of prior studies have been inconclusive about the ocular effects of thiazolidinediones on diabetic macular edema (DME). We evaluated, in patients with type 2 diabetes (T2D), the...
View ArticleError in Text in: Role of Intensive Glucose Control in Development of Renal...
Error in Text. In the Review Article titled “Role of Intensive Glucose Control in Development of Renal End Points in Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis” by Coca et al,...
View ArticleThe Other Side of Quality Improvement in Diabetes for Seniors A Proposal for...
The management of diabetes poses challenges at all levels, from affected individuals to society as a whole. Microvascular complications of diabetes have been attributed to poor glycemic control since...
View ArticleIs Sitting Harmful to Health? It Is Too Early to Say
Van der Ploeg et al analyzed prospectively collected data from a large population-based cohort and found that, regardless of age, sex, body mass index, self-rated health, level of physical activity,...
View ArticleHealthful Dietary Patterns and Type 2 Diabetes Mellitus Risk Among Women With...
BackgroundType 2 diabetes mellitus (T2DM) has reached epidemic proportions. Women with gestational diabetes mellitus (GDM) are at high risk for T2DM after pregnancy. Adherence to healthful dietary...
View ArticleUse of a Single Target Blood Pressure Level in Type 2 Diabetes Mellitus for...
For more than 15 years, all major clinical practice guidelines have recommended a target blood pressure (BP) of less than 130/80 mm Hg for patients with diabetes mellitus (DM). This BP value is based...
View ArticleIntensive and Standard Blood Pressure Targets in Patients With Type 2...
BackgroundTreatment of hypertension in patients with diabetes mellitus (DM) has been shown to improve cardiovascular outcomes; however, the value of intensive blood pressure (BP) targets remains...
View ArticleA Prospective Study of Weight Training and Risk of Type 2 Diabetes Mellitus...
BackgroundThe role of weight training in the primary prevention of type 2 diabetes mellitus (T2DM) is largely unknown.MethodsTo examine the association of weight training with risk of T2DM in US men...
View ArticlePhysical Activity and Mortality in Individuals With Diabetes Mellitus A...
BackgroundPhysical activity (PA) is considered a cornerstone of diabetes mellitus management to prevent complications, but conclusive evidence is lacking.MethodsThis prospective cohort study and...
View ArticleThe Other Side of Quality Improvement in Diabetes for Seniors A Proposal for...
The management of diabetes poses challenges at all levels, from affected individuals to society as a whole. Microvascular complications of diabetes have been attributed to poor glycemic control since...
View ArticleHealthful Dietary Patterns and Type 2 Diabetes Mellitus Risk Among Women With...
BackgroundType 2 diabetes mellitus (T2DM) has reached epidemic proportions. Women with gestational diabetes mellitus (GDM) are at high risk for T2DM after pregnancy. Adherence to healthful dietary...
View ArticleParticipatory Surveillance of Hypoglycemia and Harms in an Online Social...
ImportanceSurveillance systems for elucidating the burden of hypoglycemia are limited.ObjectiveTo quantify experiences of hypoglycemia and related harms, members of an international online diabetes...
View ArticleGlucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute...
ImportanceAcute pancreatitis has significant morbidity and mortality. Previous studies have raised the possibility that glucagonlike peptide 1 (GLP-1)–based therapies, including a GLP-1 mimetic...
View ArticleGlucagonlike Peptide 1–Based Drugs and Pancreatitis: Clarity at Last, but...
The worldwide prevalence of type 2 diabetes mellitus (T2DM) is approaching 100 million. Most affected individuals are treated for decades. Not surprisingly, the market for drug treatment of T2DM is...
View ArticleParticipatory Surveillance of Hypoglycemia and Harms in an Online Social...
ImportanceSurveillance systems for elucidating the burden of hypoglycemia are limited.ObjectiveTo quantify experiences of hypoglycemia and related harms, members of an international online diabetes...
View ArticleThe Status of Baby Boomers' Health in the United States The Healthiest...
From 1946 through 1964, 78 million children (“baby boomers”) were born in the United States. In 2010, baby boomers made up 26.1% of the US population. Medicine has improved significantly during baby...
View ArticleBenefits of Participation in Diabetes Group Visits After Trial Completion
Group medical clinics (GMCs) represent a potentially scalable and sustainable intervention for patients with diabetes. A recent trial randomized 239 patients with uncontrolled diabetes (hemoglobin A1c...
View ArticleGlucagonlike Peptide 1–Based Drugs and Pancreatitis Clarity at Last, but What...
The worldwide prevalence of type 2 diabetes mellitus (T2DM) is approaching 100 million. Most affected individuals are treated for decades. Not surprisingly, the market for drug treatment of T2DM is...
View Article
